Related Experiment Video
Updated: Jun 5, 2026

Humanized Mediator Release Assay as a Read-Out for Allergen Potency
Published on: June 29, 2021
Histamine H₄ receptor: a novel target for inflammation therapy
C Saravanan1, S K Bharti, S Jaggi
1Pharmaceutical Chemistry Research Laboratory, Department of Pharmaceutics, Institute of Technology, Banaras Hindu University, Varanasi- 221005, India.
The newly discovered histamine H₄ receptor plays a key role in inflammation and allergies. Research explores its structure, function, and the development of targeted H₄ receptor antagonists for therapeutic potential.
Area of Science:
- Pharmacology
- Immunology
- Genomics
Background:
- Histamine receptors H₁, H₂, and H₃ were previously known.
- The human genome sequencing revealed the histamine H₄ receptor.
- The H₄ receptor shares homology with H₃ but has distinct pharmacological properties.
Purpose of the Study:
- To review the structure, expression, and sequence homology of the H₄ receptor.
- To discuss the structure-activity relationship (SAR) of H₄ receptor ligands.
- To focus on the anti-inflammatory effects of H₄ receptor antagonists.
Main Methods:
- Bioinformatic analysis of H₄ receptor sequence and homology.
- Review of published literature on H₄ receptor ligands and their SAR.
- Analysis of in vivo studies on H₄ receptor antagonists, including JNJ7777120.
Main Results:
- The H₄ receptor is primarily expressed in immune cells like mast cells and leukocytes.
- Selective H₄ receptor agonists and antagonists have been developed.
- H₄ receptor antagonists, such as JNJ7777120, demonstrate anti-inflammatory effects.
Conclusions:
- The H₄ receptor is a significant target for modulating inflammatory and allergic responses.
- Understanding H₄ receptor SAR is crucial for designing effective therapeutics.
- H₄ receptor antagonists show promise for treating inflammatory conditions.
Related Concept Videos
Gastritis II: Pathophysiology
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Inflammation
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Acute Inflammation III: Local and Systemic Effects
Acute Inflammation I: Inflammatory Response
